Citation Tools

Download PDFPDF

Original research
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study

Download to a citation manager

Cite this article as:
Fleischmann R, Mysler E, Bessette L, et al
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study